AbbVie
Institution Profile
Recognized for Excellence Few pharmaceutical companies have reshaped modern medicine as profoundly as AbbVie. With a relentless drive for innovation in immunology, oncology, and neuroscience, AbbVie has introduced some of the most widely prescribed and life-changing treatments in the world. At the heart of its impact is Humira (adalimumab), one of the most successful biologic therapies ever developed, used to treat rheumatoid arthritis, Crohn's disease, psoriasis, and other autoimmune conditions. In oncology, AbbVie has revolutionized cancer treatment with Imbruvica (ibrutinib), a game-changing therapy for blood cancers like chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. Beyond these blockbusters, AbbVie continues to push the boundaries of medicine, advancing targeted therapies in neurology, aesthetics, and virology. Its acquisition of Allergan brought leading aesthetic treatments like Botox and Juvederm into its portfolio. With a commitment to scientific discovery, cutting-edge R&D, and patient-focused solutions, AbbVie stands as a Med Honors Top Pharmaceutical Innovator, shaping the future of global healthcare.
Profile last updated: July 9, 2026
2026 TOP PHARMACEUTICAL INNOVATORS
AbbVie



